Cioteronel

Drug Profile

Cioteronel

Alternative Names: CPC 10997; Cyoctol; X-Andron

Latest Information Update: 31 Aug 2007

Price : $50

At a glance

  • Originator Chantal Pharmaceuticals
  • Class Antiacnes; Antineoplastics; Hormones
  • Mechanism of Action Testosterone congener inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Acne; Alopecia; Benign prostatic hyperplasia; Keloids; Mycoses

Most Recent Events

  • 19 Feb 2001 Discontinued - Phase-II for Alopecia in USA (Topical)
  • 19 Feb 2001 A clinical study has been added to the pharmacokinetics section
  • 14 Aug 2000 Discontinued - Preclinical for Mycoses in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top